Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease

Published:2017-09-20 Issue: Volume:8 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

de Assis Adriano M.,Saute Jonas Alex Morales,Longoni Aline,Haas Clarissa Branco,Torrez Vitor Rocco,Brochier Andressa Wigner,Souza Gabriele Nunes,Furtado Gabriel Vasata,Gheno Tailise Conte,Russo Aline,Monte Thais Lampert,Castilhos Raphael Machado,Schumacher-Schuh Artur,D’Avila Rui,Donis Karina Carvalho,de Mello Rieder Carlos Roberto,Souza Diogo Onofre,Camey Suzi,Leotti Vanessa Bielefeldt,Jardim Laura Bannach,Portela Luis Valmor

Funder

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Frontiers Media SA

Subject

Neurology (clinical),Neurology

Reference33 articles.

1. Machado Joseph disease: clinical and genetic aspects, and current treatment;Saute;Expert Opin Orphan Drugs,2015

2. Epidemiology and population genetics of degenerative ataxias;Sequeiros;Handb Clin Neurol,2012

3. Spinocerebellar ataxias in Brazil – frequencies and modulating effects of related genes;de Castilhos;Cerebellum,2014

4. Spinocerebellar ataxia type 3/Machado-Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions;Souza;Clin Genet,2016

5. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features;Durr;Ann Neurol,1996

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Mulberry Silage Supplementation on the Carcass Fatness and Long-Chain Fatty Acid Composition of Growing Lambs Compared with Traditional Corn Silage;Foods;2024-08-29

2. Specific Biomarkers in Spinocerebellar Ataxia Type 3: A Systematic Review of Their Potential Uses in Disease Staging and Treatment Assessment;International Journal of Molecular Sciences;2024-07-24

3. Altered Metabolic Signaling and Potential Therapies in Polyglutamine Diseases;Metabolites;2024-05-31

4. The Role of NRF2 in Trinucleotide Repeat Expansion Disorders;Antioxidants;2024-05-26

5. A comprehensive review of iPS cell line-based disease modelling of the polyglutamine spinocerebellar ataxias 2 and 3: a focus on the research outcomes;Annals of Medicine & Surgery;2024-03-19